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NOTES AND COMMENTS 
The Second International Symposium in Infection Models in 
Antimicrobial Chemotherapy 
In July 1996 (17-20), two years after the first edition 
held in Helsinore (Denmark), the second symposium 
on the role of animal models in the investigation of 
antimicrobial chemotherapy took place in Reykjavik, 
Iceland, under the auspices of the International Society 
for Antiinfective Pharmacology (ISAP) and European 
Network for the Study of Experimental Infections 
(ENSEI), a working group of the European Society 
of Clinical Microbiology and Infectious Diseases 
(ESCMID). This symposium was chaired by Professor 
Sigurdur Gudmundsun. 
Several aspects of animal models of infections were 
discussed through main lectures, poster presentations 
and technical demonstrations: development of new 
models, pathophysiologic investigations leading to 
potentially new therapeutic targets and evaluation of 
new drugs or new modalities of administration of 
antiinfectives, in order to improve efficacy, reduce 
toxicity or prevent emergence of resistance. Special 
attention was paid to the ethical questions raised by the 
use of animal models: why do we need them? How 
could we insure that their use is scientifically sound and 
that the conditions of care to the animals are definitely 
humane? 
The Editorial Board of CMI has selected s i x  notes 
coming from the reports of this symposium, as they 
were thought to illustrate some of the current uses of 
and main questions raised by the models and to be 
of potential general interest for the readership of the 
Journal. These notes will appear divided into two parts 
in two consecutive issues. 
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Mycobacteria are major pathogens for humans. The 
recent increasing interest in these bacteria is justified, 
since tuberculosis remains the main cause of death due 
to an infectious disease, leprosy is still an important 
public-health problem in many developing countries, 
and the atypical mycobacteria, often considered, in the 
recent past, as harmless, are more and more recognized 
as major opportunistic pathogens, especially among 
patients with AIDS. The natural or acquired resistance 
of these bacteria to many antimicrobial agents and their 
ability to escape from some immune defense mech- 
anisms demonstrate the need to develop experimental 
models. 
MYCOBACTERIUM AVIUM 
Atypical mycobacteria are emerging pathogens among 
immunosuppressed patients. The Mycobacterium aviurn 
complex, including the two species M.  avium and, to a 
lesser extent, M.  irztracellulare, is a common cause of 
disseminated infection in patients with AIDS. Several 
experimental models of M .  auium infection have been 
553 
